Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan

计划入组 60 人 · 首次发布于 2017 年 5 月 10 日

Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic Nephropathy

计划入组 60 人 · 首次发布于 2011 年 2 月 21 日

Renoprotective Effects of Dulaglutide in Patients With Type 2 Diabetic Nephropathy

计划入组 300 人 · 首次发布于 2023 年 12 月 27 日

Diabetic nephropathy stem cell therapy (Kidswell Bio)

MR antagonist (diabetic nephropathy/hypertension/heart failure )

NN-6561

Inreda Diabetic BV

Netherlands

Inreda Diabetic B.V.

Netherlands

MEREO BIOPHARMA 2 LIMITED

United Kingdom

Palatin's Bremelanotide Shows Promise in Phase IIb Trial for Diabetic Nephropathy

Palatin's Melanocortin Agonist Shows Promising Results in Phase 2b Diabetic Kidney Disease Trial

Novo Nordisk's Cagrilintide/Semaglutide Combo Shows Superior Weight Loss in Phase III Trial